Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Al |
| Molecular Weight | 26.9815386 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Al]
InChI
InChIKey=AZDRQVAHHNSJOQ-UHFFFAOYSA-N
InChI=1S/Al.3H
| Molecular Formula | Al |
| Molecular Weight | 26.9815386 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Aluminum is an element with an atomic number of 13. On the periodic table of elements its symbol is Al. It belongs to a group of metals including lead and tin. Aluminum has been used for a long time. During Ancient Egypt, aluminum oxides were used in their glazes and pottery. The Romans also used this metallic element. During the 1800s, advances in research made it possible to produce pure aluminum.
Aluminium is used in a huge variety of products including cans, foils, kitchen utensils, window frames, beer kegs and aeroplane parts. This is because of its particular properties. It has low density, is non-toxic, has a high thermal conductivity, has excellent corrosion resistance and can be easily cast, machined and formed. It is also non-magnetic and non-sparking. It is the second most malleable metal and the sixth most ductile. It is often used as an alloy because aluminium itself is not particularly strong. Alloys with copper, manganese, magnesium and silicon are lightweight but strong. They are very important in the construction of aeroplanes and other forms of transport. Aluminium is a good electrical conductor and is often used in electrical transmission lines. It is cheaper than copper and weight for weight is almost twice as good a conductor. When evaporated in a vacuum, aluminium forms a highly reflective coating for both light and heat. It does not deteriorate, like a silver coating would. These aluminium coatings have many uses, including telescope mirrors, decorative paper, packages and toys. Aluminium has no known biological role. Aluminium can accumulate in the body, and a link with Alzheimer’s disease has been suggested but not proven. Aluminum-containing raw materials are used safely and extensively in cosmetics, pharmaceuticals and over-the-counter (OTC) drug products. In cosmetics, they function as pigments and thickening agents. Aluminum compounds also function as active ingredients in OTC drugs such as antacids and antiperspirants. Aluminum-containing ingredients have several uses in cosmetics and personal care products. Aluminum salts are used as antiperspirants to control sweat. Antiperspirant ingredients are regulated as over-the-counter (OTC) drugs by the U.S. Food and Drug Administration (FDA). A manufacturer can only use the aluminum active ingredients that have been approved as safe and effective by the FDA as listed in the OTC antiperspirant monograph. These products can only be used according to the guidelines established in this monograph. Aluminum may also be present in cosmetic colors. Aluminum powder is FDA approved and may be safely used in coloring externally applied cosmetics, including cosmetics intended for use in the area of the eye, [21 CFR §73.2645 Aluminum powder.]. In addition, aluminum is a common component in other cosmetic colors where it may be used as a substrate upon which another color is precipitated. Because the resulting color is not water-soluble, this can prevent ‘bleeding’, for example with lipstick. There are other uses of aluminum-containing ingredients in cosmetics, such as use as thickening agents. Under federal law, the safety of all ingredients must be substantiated by the manufacturer of the product before it is placed on the market. Aluminum compounds (alum) are the most widely used adjuvants in veterinary and human vaccines. Alum facilitates effectiveand long-lasting protective immunity in hosts, mainly by inducing antibody responses. Alum was found toinduce endogenous CD4+T cells and antibody production as well as to induce priming of CD8+T cells. These effects are shown to beindependent of the inflammasome. Novel findings of unexpected beneficial effects of decreased HBV (Hepatitis B virus) viral load and HBeAg seroconversion in chronically infected patients, as well as significant tumor suppression in experimental mice following multiple alum-only injections were examined, revealing alum's potential clinical applications beyond its use as a simple tool in antigen preparation.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Aluminum trichloride inhibits osteoblast mineralization via TGF-β1/Smad signaling pathway. | 2016-01-25 |
|
| Neuroprotective role of hydroalcoholic extract of Vitis vinifera against aluminium-induced oxidative stress in rat brain. | 2014-03 |
|
| Assessment of infantile mineral imbalances in autism spectrum disorders (ASDs). | 2013-11-11 |
|
| Protective effects of copper against aluminum toxicity on acetylcholinesterase and catecholamine contents of different regions of rat's brain. | 2013-09 |
|
| The metal transporter SMF-3/DMT-1 mediates aluminum-induced dopamine neuron degeneration. | 2013-01 |
|
| p38/AP-1 pathway in lipopolysaccharide-induced inflammatory responses is negatively modulated by electrical stimulation. | 2013 |
|
| How aluminum adjuvants could promote and enhance non-target IgE synthesis in a genetically-vulnerable sub-population. | 2012-09-13 |
|
| Molecular dynamics simulations of iron- and aluminum-loaded serum transferrin: protonation of Tyr188 is necessary to prompt metal release. | 2012-09-04 |
|
| Aluminum maltolate induces primary rat astrocyte apoptosis via overactivation of the class III PI3K/Beclin 1-dependent autophagy signal. | 2012-03 |
|
| Transgenic nematodes as biosensors for metal stress in soil pore water samples. | 2012-03 |
|
| The disruption of L-carnitine metabolism by aluminum toxicity and oxidative stress promotes dyslipidemia in human astrocytic and hepatic cells. | 2011-06-24 |
|
| [The effects of caspase-3 siRNA on the neurobehavior of mice exposed to aluminum]. | 2011-05 |
|
| Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex. | 2011-01-27 |
|
| A novel approach for a toxicity prediction model of environmental pollutants by using a quantitative structure-activity relationship method based on toxicogenomics. | 2011 |
|
| Metal ions affecting the skin and eyes. | 2011 |
|
| Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex. | 2010-09 |
|
| Physiological, molecular, and cellular mechanisms of impaired seawater tolerance following exposure of Atlantic salmon, Salmo salar, smolts to acid and aluminum. | 2010-08-01 |
|
| Microsomal Ca2+ flux modulation as an indicator of heavy metal toxicity. | 2010-07 |
|
| Effects of acidic water and aluminum exposure on gill Na(+), K(+)-ATPase alpha-subunit isoforms, enzyme activity, physiology and return rates in Atlantic salmon (Salmo salar L.). | 2010-05-05 |
|
| Bax gene silencing: a potential intervention in aluminum-induced neural cell death. | 2010-04-14 |
|
| Evaluation of the protective role of melatonin on the behavioral effects of aluminum in a mouse model of Alzheimer's disease. | 2009-11-09 |
|
| APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. | 2009-11 |
|
| Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. | 2009-02-15 |
|
| Susceptibility of mitochondrial superoxide dismutase to aluminium induced oxidative damage. | 2009-01-31 |
|
| Effects of short-term acid and aluminum exposure on the parr-smolt transformation in Atlantic salmon (Salmo salar): disruption of seawater tolerance and endocrine status. | 2008-08 |
|
| [Selection of bax siRNA sequences and its influence on aluminum induced glioma cell apoptosis]. | 2008-05 |
|
| An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. | 2007-09 |
|
| Involvement of oxidative stress in the impairment in biliary secretory function induced by intraperitoneal administration of aluminum to rats. | 2007-06 |
|
| Upregulation of LITAF mRNA expression upon exposure to TiAlV and polyethylene wear particles in THP-1 macrophages. | 2007-04 |
|
| Aluminum-induced mitochondrial dysfunction leads to lipid accumulation in human hepatocytes: a link to obesity. | 2007 |
|
| Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors. | 1997-05 |
|
| Neuronal gene expression in aluminum-induced neurofibrillary pathology: an in situ hybridization study. | 1997 |
|
| Aluminum alters iron and manganese uptake and regulation of surface transferrin receptors in primary rat oligodendrocyte cultures. | 1996-05-06 |
|
| Inhibition of transcription factor IIIA-DNA interactions by xenobiotic metal ions. | 1996-03-01 |
|
| [D-Pen2,D-Pen5]enkephalin, a delta opioid agonist reduces endogenous aluminum content in the rat central nervous system. | 1995-05 |
|
| Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. | 1993-01-15 |
|
| [Environmental factors in western Pacific foci of ALS and a possible pathogenetic role of aluminum (Al) in motor neuron degeneration]. | 1991-12 |
|
| Iron uptake by human reticulocytes at physiologic and sub-physiologic concentrations of iron transferrin: the effect of interaction with aluminum transferrin. | 1991-06-01 |
|
| Effects of diabetes mellitus and aluminum toxicity on myocardial calcium transport. | 1990-12-17 |
|
| [The toxicity of aluminum on intake into the body with drinking water]. | 1990-09 |
|
| Cerebrospinal fluid aluminum levels following deferoxamine. | 1990-08 |
|
| Aluminum inhibits hemoglobin synthesis but enhances iron uptake in Friend erythroleukemia cells. | 1990-02 |
|
| Neuronal gene expression in aluminum myelopathy. | 1989-03 |
|
| Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. | 1989 |
|
| Exacerbation of aluminium encephalopathy after treatment with desferrioxamine. | 1989 |
|
| Aluminum neurotoxicity: altered expression of cytoskeletal genes. | 1988-04 |
|
| Grand mal fitting in a patient on regular haemodialysis treatment and receiving desferrioxamine therapy. | 1988 |
|
| Effects of long-term in vitro exposure to aluminum, cadmium or lead on differentiation and cholinergic receptor expression in a human neuroblastoma cell line. | 1987-12 |
|
| Age related decline in aluminum-activated human platelet adenylate cyclase: post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer type. | 1986-09-29 |
|
| Thrombocytopenia associated with intravenous desferrioxamine. | 1985-10 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27004761
In the phase II B clinical trial, 74 hepatitis B virus patients with a viral load 4100 000 copies/mL and a serum ALT (alanine transaminase) oftwo to ten times the upper limit of normal were injected with 1 mL 0.1% Aluminum emulsion intramuscularly once every four weeks, for a total of six injections.
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:12:19 GMT 2025
by
admin
on
Mon Mar 31 18:12:19 GMT 2025
|
| Record UNII |
CPD4NFA903
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 178.3297
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
||
|
WHO-ATC |
D10AX01
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
||
|
CFR |
21 CFR 176.170
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
||
|
DSLD |
264 (Number of products:9)
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
||
|
EPA PESTICIDE CODE |
111
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
||
|
NCI_THESAURUS |
C637
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7429-90-5
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
DTXSID3040273
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
D000535
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
100000092806
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
28984
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
DB01370
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
1311504
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
m1589
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | Merck Index | ||
|
33629
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
5359268
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
507
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
C68232
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
CPD4NFA903
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
INS-173
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
231-072-3
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
CPD4NFA903
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
SUB12808MIG
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY | |||
|
SUB130454
Created by
admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|